Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery.
Cystoid macular edema (CME) is an important cause of visual impairment following phacoemulsification surgery. Imatinib is a new drug that is being used as adjunctive therapy in the management of various malignancies. A reported ocular side effect of this drug is spontaneous retinal edema. We report the case of a patient on imatinib who developed significant premature CME following uneventful phacoemulsification surgery. This resolved soon after cessation of imatinib therapy, and there was an improvement in visual acuity.
Division of Ophthalmology, Queens Medical Centre, Nottingham, United Kingdom. imranmasood777@gmail.com
Imran
I
Masood
Anil
A
Negi
Harminder S
HS
Dua
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D041623:Tomography, Optical Coherence
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate